Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
127Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $6.39M | $-117.26M | $-12.48 |
| 2024 | $2.27M | $-83.58M | $-9.37 |
| 2023 | $0.00 | $-81.17M | $-53.09 |
| 2022 | $0.00 | $-58.03M | $-227.58 |
| 2021 | $0.00 | $-21.96M | $-4.94 |
Social Signal Score
Earnings
Wed, Nov 11(in 3 months)
Consensus estimate $-1.25 per share
Typical surprise +3.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$-1.07 vs $-1.34beat
- Thu, May 7$-1.69 vs $-1.60miss
- Thu, Mar 12$-5.32 vs $-1.93miss
- Wed, Nov 12$-1.92 vs $-2.61beat
- Tue, Aug 12$-2.74 vs $-2.54miss
- Wed, May 7$-2.49 vs $-2.60beat
Estimates and results for KRRO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
KRROhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newszacks.com·5d ago·Positive
All You Need to Know About Korro Bio, Inc. (KRRO) Rating Upgrade to Buy Korro Bio, Inc. (KRRO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
View source ↗